Menlo Therapeutics Inc. (MNLO) Prices 7M Share IPO at $17/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Menlo Therapeutics (MNLO) IPO Opens Up 21%
January 25, 2018 10:29 AM ESTToday's IPO for Menlo Therapeutics Inc. (NASDAQ: MNLO) opened for trading at $20.50 after pricing its nitial public offering of 7,000,000 shares of common stock at a public offering price of $17.00 per share.
The Company has also granted the underwriters a 30-day option to purchase... More
